Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines

Journal of Bone and Mineral Research

Volumn 17, Issue 5, 2002, Pages 774-781

  Ono, Katsuhiro ^a   Akatsu, Takuhiko ^a   Murakami, Takehiko ^a   Kitamura, Ryuichi ^a   Yamamoto, Michiko ^b   Shinomiya, Nariyoshi ^a   Rokutanda, Makoto ^a   Sasaki, Tomoyo ^c   Amizuka, Norio ^c   Ozawa, Hidehiro ^c   Nagata, Naokazu ^a   Kugai, Nobuo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NIIGATA UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Bone metastasis; Mammary carcinoma; Osteoclast; Prostaglandin E2 cyclo oxygenase 2

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; PROSTAGLANDIN E2; TILMACOXIB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE MARROW CELL; BONE METASTASIS; BREAST CARCINOMA; CANCER MODEL; CARCINOMA CELL; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; HINDLIMB; HISTOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NORTHERN BLOTTING; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; STROMA CELL; TRABECULAR BONE;

ANIMALS; BONE NEOPLASMS; COCULTURE TECHNIQUES; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GLYCOPROTEINS; ISOENZYMES; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; OSTEOCLASTS; OSTEOLYSIS; OSTEOPROTEGERIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0036241535     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2002.17.5.774     Document Type: Article

References (36)

1. Mechanisms of bone metastasis
2. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone
3. Cancer and bone
4. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL
5. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer
6. Bone resorption induced by a metastatic human melanoma cell line
7. Mechanism of bone destruction in the development of skeletal metastases
8. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor
9. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts
10. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity
11. Therapeutic approaches to bone diseases
12. 2 and leukemia inhibitory factor and support osteoclast formation in vitro via stromal cell-dependent pathway
13. Mouse mammary carcinoma cell line (BALB/c-MC) stimulates osteoclast formation from bone marrow cells through cell-to-cell contact
14. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2
15. Prostaglandin endoperoxide synthase gene structure: Identification of the transcriptional start site and 5′-flanking regulatory sequences
16. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
17. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: Differential elevation of cyclooxygenase 2 in inflammatory joint diseases
18. Osteoclast-like cell formation and its regulation by osteotropic hormones in a mouse bone marrow cell culture
19. Osteoclast ontogeny and function
20. Histochemical demonstration of acid phosphatase with naphthol AS-phosphate
21. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function
22. Selective preparation and characterization of membranous and soluble forms of alkaline phosphatase from rat tissues. A comparison with the serum enzyme
23. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
24. Leukotriens, lipoxins and PAF
25. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
26. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
27. Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells
28. Prostaglandins and related lipids
29. Observations on a cell line producing mammary tumor virus
30. Establishment and characterization of new murine mammary tumor cell line, BALB/c-MC
31. Tumor necrosis factor-α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction
32. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro
33. Breast cancer cells interact with osteoblasts to support osteoclast formation
34. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
35. Prostaglandins and breast cancer
36. Technique for the primary culture of human breast cancer cells and measurement of their prostaglandin secretion